Skip to Content
Søk Menu

IHS4-55: A Validated Scoring System for Clinical Trials on Hidradenitis Suppurativa

IHS4-55, a validated outcome, addresses HiSCR limitations and includes draining tunnels to analyze patients with low abscess and nodule count but many tunnels, making it a useful primary outcome for clinical trials and daily practice.

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Relaterat innehåll

Thrasyvoulos Tzellos

IL-17 Targeted Drugs Signal Hope for Hidradenitis Suppurativa Patients

/ Thrasyvoulos Tzellos
EADV23Hidradenitis Suppurativa Play the Video 2:40

Focus on Sleep Disturbance and Hidradenitis Suppurativa 

/ BestPractice Nordic
EADV23Hidradenitis Suppurativa

Greetings from AAD in New Orleans

/ Carsten Sauer Mikkelsen
Alopecia areataHidradenitis Suppurativa

Prevalence of Hidradenitis Suppurativa in Nuuk, Greenland

/ Sofia Hedvig Christina Botvid / Rune Kjærsgaard Andersen / Dorra Bouazzi / Simon Francis Thomsen / Lone Storgaard Hove / Ditte Marie Saunte / Gregor Borut Ernst Jemec
Hidradenitis SuppurativaHudsjukdom
Mattias Henning

The Effect of Covid-19-associated Stress on the Health of Blood Donors with Symptoms of Hidradenitis Suppurativa, Hyperhidrosis or Psoriasis

/ Mattias Henning
COVID-19Hidradenitis SuppurativaNCDV22 Play the Video 2:44
Elisabeth Hjardem Taudorf

Can a PDE4-inhibitor be the next approved drug for the treatment of hidradenitis suppurativa?

/ Elisabeth H. Taudorf
Hidradenitis SuppurativaNCDV22 Play the Video 5:24
Dorra Bouazzi

Can clinical Subtypes of Hidradenitis Suppurativa lead to more individual treatment?

/ Dorra Bouazzi
Hidradenitis SuppurativaNCDV22 Play the Video 2:18
Rune Kjærsgaard Andersen

Increased Cancer Incidence Among Patients with Hidradenitis Suppurativa

/ Rune Kjærsgaard Andersen
Hidradenitis SuppurativaNCDV22 Play the Video 5:02
Back to top